Gemox as First and Second Line Therapy in Unknown Primary Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-07-17
- Last Posted Date
- 2012-08-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT00353145
- Locations
- 🇺🇸
U.T. M.D. Anderson Cancer Center, Houston, Texas, United States
Effects of Cancer Symptoms on Caregivers
- Conditions
- Interventions
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 199
- Registration Number
- NCT00351988
- Locations
- 🇺🇸
Lyndon Baines Johnson Hospital, Houston, Texas, United States
🇺🇸Jackson Memorial, Miami, Florida, United States
🇺🇸Ben Taub General Hospital, Houston, Texas, United States
The Effect of Donepezil on Sedation and Other Symptoms
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2016-05-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT00352664
- Locations
- 🇺🇸
U.T. M.D. Anderson Cancer Center, Houston, Texas, United States
Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2016-02-03
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 54
- Registration Number
- NCT00352391
- Locations
- 🇺🇸
Eisenhower Army Medical Center, Fort Gordon, Georgia, United States
🇺🇸Conemaugh Memorial Medical Center, Johnstown, Pennsylvania, United States
🇺🇸University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)
- First Posted Date
- 2006-07-11
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 90
- Registration Number
- NCT00350818
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)
- First Posted Date
- 2006-07-07
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT00349596
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)
- Conditions
- Interventions
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2012-10-22
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00346801
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Elizabeth Registry for Low Grade Ovarian Cancer
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2015-10-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT00345709
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2012-08-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT00338988
- Locations
- 🇺🇸
U.T. M.D. Anderson Cancer Center, Houston, Texas, United States
Lymphodepletion Plus Adoptive Cell Transfer with or Without Dendritic Cell Immunization in Patients with Metastatic Melanoma
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1230
- Registration Number
- NCT00338377
- Locations
- 🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States